In the Media

In its 15 years of operation, the Qatar National Research Fund (QNRF) has nurtured a thriving culture of scientific research and built the much-needed next generation of scientists and engineers to advance knowledge and education in Qatar, said QNRF Executive Director Dr. Abdul Sattar Al Taie during a public lecture given at Texas A&M University at Qatar.

Qatar Foundation’s Qatar National Research Fund (QNRF) has called for research proposals that can help the country improve its recovery from COVID-19 and support the journey towards normalcy.

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have found that more than one in 10 of the population in Asia is infected with the herpes simplex virus type 2 (HSV-2), yet prevalence is declining by 2% yearly.

Researchers at Weill Cornell Medicine-Qatar (WCM-Q), in partnership with the World Health Organization (WHO), have produced a comprehensive report on the hepatitis C virus epidemic in the Eastern Mediterranean region, offering guidance on eliminating the disease by the WHO’s 2030 target date.

Team Qatar, the STEM-vengers, have finished in 19th place among 175 teams worldwide in the FIRST Global Challenge.

The team is part of Texas A&M University at Qatar’s STEM Hub Robotics Club (SHRC), a joint initiative between the QF partner university and the Qatar National Research Fund (QNRF).

Wastewater management remains a global challenge to the oil and gas (O&G) industry. In Qatar, the regulations imposed by Qatar Petroleum require a 50% reduction in liquid discharge from all oil and gas processing facilities.

Five research projects aiming to support and advance Qatar’s precision medicine and genomic research infrastructure have been awarded grants by Qatar National Research Fund (QNRF) and Qatar Genome Programme – both members of Qatar Foundation (QF) – under the Path towards Precision Medicine (PPM) research programme.

A rapidly growing field in cancer care is precision oncology – that is tailored treatment for patients based on their tumor’s genetic signatures. However, treatment based solely on genetics appear to be unsuccessful for many, indicating that there are other factors involved. The question is: How do we make precision medicine more precise?

Dr. Khaled Khan and Dr. Armstrong Nhlabatsi from the College of Engineering at Qatar University (QU) have recently obtained a US Patent (No. 10,713,355) for their invention on adaptive security.